Is The Pennant Group, Inc. overvalued or undervalued?

As of 29 July 2025, The Pennant Group, Inc. has moved from a very expensive valuation to fair. The company appears fairly valued based on its current metrics. Key ratios include a P/E ratio of 35, an EV to EBITDA of 21.52, and a PEG ratio of 0.70, indicating potential for growth relative to its price. In comparison to peers, Addus HomeCare Corp. has a P/E of 22.05, while Hims & Hers Health, Inc. is considered expensive with a P/E of 54.76.
Despite the fair valuation, The Pennant Group has underperformed relative to the S&P 500, with a one-year return of -29.24% compared to the index's 17.14%, highlighting a significant divergence in performance.